THE NEURAMINIC ACID CONTENT OF CEREBROSPINAL FLUID AS AFFECTED BY NEUROLOGICAL DISEASES*

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The neuraminic acid content of cerebrospinal fluid as affected by neurological diseases.

Interest in the presence of neuraminic acid in human cerebrospinal fluid (CSF) and the variations in its concentration is derived from the possibility that these may reflect some aspect of central nervous metabolic activity. This, in turn, is based on the fact that neuraminic acid constitutes a part of the molecular structure of those water soluble glycolipids of brain that are generally referr...

متن کامل

Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.

Cerebrospinal fluid gamma-aminobutyric acid (CSF-GABA) was analysed by radioreceptor assay in 16 normal controls and 84 patients with various neurological and psychiatric diseases. In patients with spinocerebellar degeneration, neuro-Behçet's syndrome and Parkinson's disease, CSF-GABA levels were decreased. On the other hand, increased CSF-GABA levels were detected in patients with meningitis.

متن کامل

Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases.

BACKGROUND The differential diagnosis between bacterial and viral meningitis is not easy in some cases. Cerebrospinal fluid (CSF) analysis is essential for establishing this diagnosis. The objectives were to quantitate lactic acid (LA) concentrations in bacterial and viral meningitis, and other central nervous system (CNS) diseases in order to evaluate the diagnostic utility of CSF LA for discr...

متن کامل

Evaluation of S100B in cerebrospinal fluid as a potential biomarker for neurological diseases in calves

S100B in cerebrospinal fluid (CSF-S100B) was measured in calves with 20 neurologic and 21 non-neurologic diseases to clarify its utility as a biomarker for neurologic diseases. The median CSF-S100B value in the neurologic disease group (43.0 ng/ml) was significantly higher than that in the non-neurologic disease group (10.2 ng/ml). As CSF-S100B levels in calves with neurologic diseases widely d...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Clinical Investigation

سال: 1959

ISSN: 0021-9738

DOI: 10.1172/jci103954